Stock listing
BOATS:FBLG FibroBiologics, Inc. Stock
US listing (BOATS) of FibroBiologics, Inc. · home listing NASDAQ:FBLG
Follow FibroBiologics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:FBLG
$0.98 USD +0.02 (+2.4%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:FBLG
- Day range
- $0.911 – $0.98 USDNov 6, 2026
- Volume
- 41,010 sharesNov 6, 2026
- Market cap
- $6.94M USDAt the close on Nov 6, 2026 · price × 7.08M shares outstanding
- 52-week range
- $0.62 – $9.60 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $283,343 USDMedian day 146,193 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:FBLG · Home | $0.98 USD | +0.023 (+2.4%) | 41,010 | $0.94 | $0.98 | $0.911 | $0.957 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:FBLG · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.98 | +0.023 | +2.4% | $0.94 | $0.98 | $0.911 | 41,010 | |
| $0.957 | -0.012 | -1.2% | $1.00 | $1.00 | $0.91 | 81,390 | |
| $0.969 | -0.021 | -2.2% | $1.04 | $1.04 | $0.941 | 59,736 | |
| $0.99 | +0.07 | +7.6% | $0.935 | $0.99 | $0.901 | 41,764 | |
| $0.92 | -0.01 | -1.1% | $0.92 | $0.96 | $0.92 | 42,364 | |
| $0.93 | +0.002 | +0.2% | $0.92 | $0.97 | $0.90 | 20,671 | |
| $0.928 | -0.039 | -4.0% | $0.94 | $0.99 | $0.923 | 17,857 | |
| $0.967 | +0.035 | +3.8% | $0.929 | $0.993 | $0.91 | 32,010 | |
| $0.932 | -0.008 | -0.9% | $0.97 | $0.99 | $0.929 | 26,590 | |
| $0.94 | -0.01 | -1.1% | $0.93 | $0.95 | $0.89 | 156,618 | |
| $0.95 | -0.07 | -6.9% | $1.02 | $1.02 | $0.95 | 111,922 | |
| $1.02 | +0.027 | +2.7% | $0.97 | $1.24 | $0.97 | 399,071 | |
| $0.993 | +0.073 | +7.9% | $0.90 | $1.00 | $0.90 | 127,507 | |
| $0.92 | -0.024 | -2.6% | $0.93 | $0.971 | $0.881 | 94,090 | |
| $0.944 | -0.027 | -2.8% | $0.98 | $0.98 | $0.94 | 170,331 | |
| $0.971 | -0.029 | -2.9% | $1.02 | $1.04 | $0.95 | 36,000 | |
| $1.00 | +0.05 | +5.3% | $0.96 | $1.05 | $0.96 | 156,200 | |
| $0.95 | -0.01 | -1.0% | $1.00 | $1.02 | $0.925 | 109,100 | |
| $0.96 | -0.04 | -4.0% | $1.00 | $1.025 | $0.933 | 80,600 | |
| $1.00 | -0.13 | -11.5% | $1.12 | $1.135 | $0.989 | 152,000 | |
| $1.13 | +0.02 | +1.8% | $1.11 | $1.20 | $1.10 | 182,300 | |
| $1.11 | -0.03 | -2.6% | $1.12 | $1.14 | $1.05 | 71,900 | |
| $1.14 | +0.01 | +0.9% | $1.16 | $1.20 | $1.07 | 233,800 | |
| $1.13 | -0.05 | -4.2% | $1.20 | $1.23 | $1.12 | 210,300 | |
| $1.18 | -0.06 | -4.8% | $1.24 | $1.24 | $1.18 | 94,100 | |
| $1.24 | +0.035 | +2.9% | $1.20 | $1.24 | $1.10 | 148,600 | |
| $1.205 | -0.095 | -7.3% | $1.32 | $1.32 | $1.16 | 140,100 | |
| $1.30 | -0.01 | -0.8% | $1.35 | $1.40 | $1.28 | 107,300 | |
| $1.31 | -0.05 | -3.7% | $1.38 | $1.41 | $1.26 | 191,800 | |
| $1.36 | -0.03 | -2.2% | $1.44 | $1.48 | $1.34 | 241,600 | |
| $1.39 | +0.03 | +2.2% | $1.35 | $1.39 | $1.33 | 55,400 | |
| $1.36 | +0.03 | +2.3% | $1.35 | $1.47 | $1.33 | 258,600 | |
| $1.33 | -0.01 | -0.7% | $1.32 | $1.45 | $1.31 | 87,300 | |
| $1.34 | -0.02 | -1.5% | $1.35 | $1.41 | $1.33 | 95,800 | |
| $1.36 | -0.07 | -4.9% | $1.46 | $1.46 | $1.29 | 116,700 | |
| $1.43 | -0.055 | -3.7% | $1.54 | $1.54 | $1.40 | 130,700 | |
| $1.485 | +0.055 | +3.8% | $1.53 | $1.587 | $1.46 | 105,100 | |
| $1.43 | -0.01 | -0.7% | $1.44 | $1.49 | $1.386 | 117,100 | |
| $1.44 | -0.11 | -7.1% | $1.55 | $1.575 | $1.44 | 177,100 | |
| $1.55 | -0.06 | -3.7% | $1.60 | $1.69 | $1.521 | 174,500 | |
| $1.61 | -0.12 | -6.9% | $1.70 | $1.736 | $1.61 | 107,300 | |
| $1.73 | -0.03 | -1.7% | $1.73 | $1.796 | $1.671 | 83,700 | |
| $1.76 | +0.05 | +2.9% | $1.73 | $1.80 | $1.62 | 135,900 | |
| $1.71 | -0.10 | -5.5% | $1.80 | $1.816 | $1.619 | 166,400 | |
| $1.81 | +0.05 | +2.8% | $1.73 | $1.90 | $1.71 | 210,456 | |
| $1.76 | -0.19 | -9.7% | $1.80 | $1.901 | $1.70 | 366,002 | |
| $1.95 | -0.16 | -7.6% | $2.17 | $2.175 | $1.865 | 639,026 | |
| $2.11 | +0.39 | +22.7% | $1.73 | $2.20 | $1.72 | 1,545,221 | |
| $1.72 | +0.28 | +19.4% | $1.46 | $1.79 | $1.401 | 508,098 | |
| $1.44 | -0.05 | -3.4% | $1.50 | $1.54 | $1.41 | 143,785 | |
| $1.49 | +0.08 | +5.7% | $1.44 | $1.52 | $1.42 | 217,830 | |
| $1.41 | +0.01 | +0.7% | $1.39 | $1.47 | $1.33 | 164,686 | |
| $1.40 | +0.05 | +3.7% | $1.34 | $1.49 | $1.33 | 191,303 | |
| $1.35 | -0.09 | -6.2% | $1.42 | $1.50 | $1.31 | 252,938 | |
| $1.44 | +0.15 | +11.6% | $1.35 | $1.489 | $1.34 | 570,614 | |
| $1.29 | +0.10 | +8.4% | $1.22 | $1.37 | $1.20 | 415,522 | |
| $1.19 | +0.05 | +4.4% | $1.17 | $1.28 | $1.14 | 390,411 | |
| $1.14 | +0.12 | +11.8% | $1.09 | $1.18 | $1.01 | 303,532 | |
| $1.02 | -0.04 | -3.8% | $1.09 | $1.12 | $0.99 | 118,931 | |
| $1.06 | -0.09 | -7.8% | $1.17 | $1.17 | $1.02 | 181,665 | |
| $1.15 | +0.04 | +3.6% | $1.11 | $1.279 | $1.106 | 386,422 | |
| $1.11 | +0.08 | +7.8% | $1.00 | $1.15 | $0.98 | 300,459 | |
| $1.03 | +0.05 | +5.1% | $0.99 | $1.05 | $0.98 | 126,112 | |
| $0.98 | +0.004 | +0.4% | $1.04 | $1.04 | $0.95 | 118,116 | |
| $0.976 | -0.044 | -4.3% | $1.04 | $1.066 | $0.96 | 170,915 | |
| $1.02 | +0.152 | +17.5% | $0.867 | $1.096 | $0.867 | 647,476 |
Splits
1 split · NASDAQ:FBLG · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation |
- Ticker
- BOATS:FBLG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 5, 2026
FibroBiologics Announces Grant of European Patent for Fibroblast Delivery of Tumor Inhibitory Agents
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 19 slides
Latest news
FibroBiologics Announces Grant of European Patent for Fibroblast Delivery of Tumor Inhibitory Agents
Nov 5, 2026
Closed $0.957 (-1.2%) on Nov 5, 2026
FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting
Oct 19, 2026
Closed $0.944 (-2.8%) on Oct 19, 2026
FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs
Oct 14, 2026
Closed $0.95 (-1.0%) on Oct 14, 2026
FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body
Oct 7, 2026
Closed $1.14 (+0.9%) on Oct 7, 2026
FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity
Sep 29, 2026
Closed $1.31 (-3.7%) on Sep 29, 2026
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer
Sep 17, 2026
Closed $1.49 (+3.8%) on Sep 17, 2026
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
Sep 3, 2026
Closed $1.76 (-9.7%) on Sep 3, 2026
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media
Sep 1, 2026
Closed $2.11 (+22.7%) on Sep 1, 2026
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
Aug 27, 2026
Closed $1.49 (+5.7%) on Aug 27, 2026
FibroBiologics Regains Compliance with Nasdaq Trading Rules
Aug 26, 2026
Closed $1.41 (+0.7%) on Aug 26, 2026
Financings
Private placement of shares of common stock and accompanying warrants
Sep 17, 2026
Closed: US$500,000 raised · US$1.675 a share · Warrants at US$1.55 for 60 months
Buyers: Hamid Khoja, Ph.D. (298,508 shares of common stock and accompanying warrants to purchase up to 298,508 shares)
Insiders: The entire placement was purchased by Chief Scientific Officer Hamid Khoja, Ph.D.
Use of proceeds: General corporate purposes and working capital
Private placement of shares of common stock (or pre-funded warrants) with series A and short-term series B warrants
Jun 29, 2026
Closed: US$3M raised · US$0.735 a share · Warrants at US$0.735 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Registered direct offering of registered direct offering
Apr 30, 2026
Closed: US$2.5M raised
Registered direct offering of common stock, with concurrent private placement of unregistered warrants
Dec 16, 2025
Closed: US$1.7M raised · US$0.33 a share · Warrants at US$0.33 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Registered direct offering of common stock, with concurrent private placement of unregistered warrants
Nov 25, 2025
Closed: US$1.5M raised · US$0.335 a share · Warrants at US$0.335 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Registered direct offering of common stock and pre-funded warrants, with concurrent private placement of unregistered warrants
Nov 20, 2025
Closed: US$4M raised · US$0.3303 a share · Warrants at US$0.3303 for 60 months
Buyers: existing shareholder (3,540,000 shares of common stock and pre-funded warrants to purchase 8,570,203 shares, paid with gold coins)
Use of proceeds: General corporate purposes, including the satisfaction of debt
Convertible promissory notes (advances under SEPA)
Jun 16, 2025
Tranche closed: US$5M in the latest tranche · D. Boral Capital LLC
Dealers: D. Boral Capital LLC (lead)
Buyers: YA II PN LTD. (Yorkville) (Up to $25 million of common stock over two years; first $15 million advanced via convertible promissory notes, $5 million funded); YA II PN, LTD. (Yorkville) (third $5 million tranche of convertible promissory notes under the SEPA)
Use of proceeds: General corporate purposes, including R&D programs and the upcoming Phase 1/2 diabetic foot ulcer clinical trial
Announced Dec 23, 2024 · Tranche closed Dec 30, 2024 · Tranche closed Jun 16, 2025
Decks
Investor Presentation (September 2026)
Investor deck · 19 slides · September 2026
Investor Day (December 2023)
Investor day · 33 slides · December 2023
FibroBiologics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 59 in the last 12 months · 118 in all · newest Nov 5, 2026 · oldest 2024
- Decks
- 2 decks · latest September 2026
Where FibroBiologics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:FBLG · Home listing | NASDAQ | United States | USD |
| BOATS:FBLG · This page | BOATS | United States | USD |
| Frankfurt:SG00 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A426UV | Lang & Schwarz | Germany | EUR |
| LS Exchange:A426UV | LS Exchange | Germany | EUR |
Log in to ask 6ix AI your own questions about FibroBiologics, Inc.